- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Deliberate Learning Can Help Providers Adapt, Says Dr Lee Norman
Keeping up-to-date on information, whether it is about clinical matters or information systems, is critical to a deliberate learning mindset that is beneficial to health care providers, says Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City.
A deliberate learning mindset is beneficial for health care providers to have, said Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City. He served as the secretary of the Kansas Department of Health and Environment from 2019 to 2021 under Governor Laura Kelly. Norman, who also served in the US Air Force and later as a colonel in the Kansas Army National Guard, spoke in March at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri.
Transcript
How can deliberate learning help health care providers be more open-minded and willing to adapt to change?
Yeah, deliberate learning—and I chose that word, well, very deliberately. And that was because a lot of times, physicians and just people in general want to close off their ears and say, there's just too much information, I just want to hunker down, do what I do, know what I know, and protect me from the rest of the world out there. Especially if people are in somewhat of a burnout situation, or they're just tired, they don’t want to learn anything new. But that's not going to carry the day, in a value-based world or a fee-for-service world.
Physicians and caregivers have to keep an open mind. I myself read probably an hour and a half a day—health systems information, clinical information, research studies, and the like—to always stay on top of things. And that is a very deliberate act. You have to stay up on things. That's deliberate learning.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
OptumRx’s Jon Mahrt Discusses “Irresponsible” Drug Pricing for Products With Multiple Indications
April 30th 2024When the same product comes to market with additional indications, irrational pricing decisions result in ever increasing prices instead of volume translating to lower costs, said Jon Mahrt, MBA, of OptumRX.
Read More
